LU79320A1 - Procede de preparation de peptides exercant une activite biologique - Google Patents

Procede de preparation de peptides exercant une activite biologique

Info

Publication number
LU79320A1
LU79320A1 LU79320A LU79320A LU79320A1 LU 79320 A1 LU79320 A1 LU 79320A1 LU 79320 A LU79320 A LU 79320A LU 79320 A LU79320 A LU 79320A LU 79320 A1 LU79320 A1 LU 79320A1
Authority
LU
Luxembourg
Prior art keywords
exercising
biological activity
preparing peptides
peptides
preparing
Prior art date
Application number
LU79320A
Other languages
English (en)
French (fr)
Inventor
W Vale
M Brown
J Rivier
Original Assignee
Salk Inst For Biological Studi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Salk Inst For Biological Studi filed Critical Salk Inst For Biological Studi
Publication of LU79320A1 publication Critical patent/LU79320A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
LU79320A 1977-03-28 1978-03-28 Procede de preparation de peptides exercant une activite biologique LU79320A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/781,580 US4105603A (en) 1977-03-28 1977-03-28 Peptides which effect release of hormones

Publications (1)

Publication Number Publication Date
LU79320A1 true LU79320A1 (fr) 1978-06-29

Family

ID=25123228

Family Applications (1)

Application Number Title Priority Date Filing Date
LU79320A LU79320A1 (fr) 1977-03-28 1978-03-28 Procede de preparation de peptides exercant une activite biologique

Country Status (19)

Country Link
US (1) US4105603A (xx)
JP (1) JPS53130687A (xx)
AT (1) AT366026B (xx)
AU (1) AU519122B2 (xx)
BE (1) BE865380A (xx)
CA (1) CA1102314A (xx)
CH (1) CH639361A5 (xx)
DE (1) DE2813327A1 (xx)
DK (1) DK131878A (xx)
ES (1) ES468241A1 (xx)
FI (1) FI780907A7 (xx)
FR (1) FR2385688A1 (xx)
GB (1) GB1564191A (xx)
IE (1) IE46862B1 (xx)
IT (1) IT1105152B (xx)
LU (1) LU79320A1 (xx)
NL (1) NL7803289A (xx)
SE (1) SE446190B (xx)
ZA (1) ZA781599B (xx)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211693A (en) * 1977-09-20 1980-07-08 The Salk Institute For Biological Studies Peptides with para-substituted phenylalanine
US4185010A (en) * 1978-12-12 1980-01-22 American Home Products Corporation Nonapeptides
US4225472A (en) * 1979-05-29 1980-09-30 American Home Products Corporation Truncated somatostatin analogs
USRE30548E (en) * 1979-08-31 1981-03-17 The Salk Institute For Biological Studies Peptides which effect release of hormones
ATE2512T1 (de) * 1979-11-27 1983-03-15 Sandoz Ag Polypeptide, verfahren zu ihrer herstellung, pharmazeutische zusammensetzungen, die diese polypeptide enthalten, und ihre verwendung.
FR2523125A1 (fr) * 1982-03-08 1983-09-16 Sanofi Sa Analogues de la somatostatine a activite biologique modifiee et medicaments en contenant
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4880778A (en) * 1986-05-12 1989-11-14 Eastman Kodak Company Combinations having synergistic growth hormone releasing activity and methods for use thereof
US4839344A (en) * 1987-06-12 1989-06-13 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
US4880777A (en) * 1987-09-01 1989-11-14 Eastman Kodak Company Synthetic peptides having growth hormone releasing activity
JPH03502329A (ja) * 1988-01-28 1991-05-30 ポリゲン　ホールディング　コーポレイション 成長ホルモン放出活性を有するポリペプチド化合物類
US6737408B1 (en) * 1997-08-07 2004-05-18 University Of Cincinnati Compounds for control of appetite, blood pressure, cardiovascular response, libido, and circadian rhythm
WO2001010892A2 (en) * 1999-08-06 2001-02-15 Genentech, Inc. Peptide antagonists of factor viia
US20060228364A1 (en) * 1999-12-24 2006-10-12 Genentech, Inc. Serum albumin binding peptides for tumor targeting
CA2921260A1 (en) * 1999-12-24 2001-06-28 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
US20050287153A1 (en) * 2002-06-28 2005-12-29 Genentech, Inc. Serum albumin binding peptides for tumor targeting
EP1757701A1 (en) 1999-12-24 2007-02-28 Genentech, Inc. Methods and compositions for prolonging elimination half-times of bioactive compounds
US20040001827A1 (en) * 2002-06-28 2004-01-01 Dennis Mark S. Serum albumin binding peptides for tumor targeting
US7164002B2 (en) 2002-02-06 2007-01-16 Genentech, Inc. FVIIa antagonists
WO2005028498A2 (en) * 2003-09-18 2005-03-31 Raven Biotechnologies, Inc. Kid3 and kid3 antibodies that bind thereto
JP4390568B2 (ja) * 2004-01-19 2009-12-24 富士通株式会社 遅延測定システム
WO2005121179A2 (en) * 2004-06-07 2005-12-22 Raven Biotechnologies, Inc. Transferrin receptor antibodies
EP1796718A2 (en) * 2004-10-05 2007-06-20 Genentech, Inc. Therapeutic agents with decreased toxicity
US7687242B2 (en) * 2005-01-12 2010-03-30 Raven Biotechnologies, Inc. KID31 and antibodies that bind thereto
JP2008538173A (ja) * 2005-01-31 2008-10-16 レイベン バイオテクノロジーズ，インコーポレイティド Ｌｕｃａ２およびそれに結合する抗体
AU2006210589B2 (en) 2005-02-02 2011-12-08 Macrogenics West, Inc. ADAM-9 modulators
WO2006084078A2 (en) * 2005-02-02 2006-08-10 Raven Biotechnologies, Inc. Jam-3 and antibodies that bind thereto
AU2006210606B2 (en) * 2005-02-03 2012-03-22 Macrogenics West, Inc. Antibodies to Oncostatin M receptor
US20070197445A1 (en) * 2006-01-18 2007-08-23 University Of Cincinnati Compounds for control of appetite
EP2094307A4 (en) * 2006-11-08 2015-08-26 Macrogenics West Inc TES7 AND THEREO BINDING ANTIBODIES
EP2421551B2 (en) 2009-04-20 2020-07-15 Allergan, Inc. Silk fibroin hydrogels and uses thereof
PL219569B1 (pl) 2010-02-19 2015-05-29 Peptaderm Spółka Z Ograniczoną Odpowiedzialnością Cykliczne tetrapeptydy i ich zastosowanie
PH12012501751A1 (en) 2010-03-04 2012-11-12 Macrogenics Inc Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
BR122016002916B8 (pt) 2010-03-04 2021-05-25 Macrogenics Inc diacorpo, molécula de ácido nucleico, composição farmacêutica e usos do diacorpo
NZ703939A (en) 2011-05-21 2016-01-29 Macrogenics Inc Cd3-binding molecules capable of binding to human and non-human cd3
RU2014110901A (ru) 2011-08-23 2015-09-27 Президент Энд Феллоуз Ов Харвард Колледж Пептидные частицы и их применение
US9487587B2 (en) 2013-03-05 2016-11-08 Macrogenics, Inc. Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
RS62304B1 (sr) 2013-03-14 2021-09-30 Macrogenics Inc Bispecifični molekuli koji su imunoreaktivni sa imunim efektorskim ćelijama koje eksprimiraju aktivirajući receptor
WO2014154891A1 (en) 2013-03-29 2014-10-02 Centre National De La Recherche Scientifique (Cnrs) Cgrp receptor agonist for hiv treatment or prevention
ES2890079T3 (es) 2014-05-29 2022-01-17 Macrogenics Inc Moléculas de unión triespecíficas y métodos de uso de las mismas
BR112017006515A8 (pt) 2014-09-29 2018-02-27 Univ Duke moléculas biespecíficas, composições, método para tratar ou prevenir infecção por hiv-1 em um indivíduo com essa necessidade, e vetor
US10501552B2 (en) 2015-01-26 2019-12-10 Macrogenics, Inc. Multivalent molecules comprising DR5-binding domains
TWI773646B (zh) 2015-06-08 2022-08-11 美商宏觀基因股份有限公司 結合lag-3的分子和其使用方法
TWI762879B (zh) 2015-07-30 2022-05-01 美商宏觀基因股份有限公司 Pd-1結合分子和其使用方法
RU2731202C2 (ru) 2015-10-08 2020-08-31 Макродженикс, Инк. Комбинированная терапия для лечения рака
JP7227007B2 (ja) 2015-12-02 2023-02-21 ストサイエンシス， インコーポレイテッド グリコシル化ｂｔｌａ（ｂ－及びｔ－リンパ球減弱因子）に特異的な抗体
EP3389714A4 (en) 2015-12-14 2019-11-13 MacroGenics, Inc. BIS-SPECIFIC MOLECULES WITH IMMUNE REACTIVITY WITH PD-1 AND CTLA-4 AND METHOD OF USE THEREOF
WO2017180813A1 (en) 2016-04-15 2017-10-19 Macrogenics, Inc. Novel b7-h3 binding molecules, antibody drug conjugates thereof and methods of use thereof
US10111929B1 (en) 2017-04-07 2018-10-30 Ez Ip, Llc Growth hormone releasing factor analogs and uses
EP4041767A1 (en) 2019-09-26 2022-08-17 StCube & Co. Antibodies specific to glycosylated ctla-4 and methods of use thereof
CN114829404B (zh) 2019-10-09 2025-09-09 斯特库比公司 对糖基化的lag3特异的抗体及其使用方法
US11596665B2 (en) 2020-06-23 2023-03-07 Chanda Zaveri Skin lightening formulations
US11951203B2 (en) 2020-08-26 2024-04-09 Chanda Zaveri Deep wrinkle vanishing compositions
US11793746B2 (en) 2020-10-01 2023-10-24 Chanda Zaveri Intense skin hydration systems and methods
US20220110852A1 (en) 2020-10-14 2022-04-14 Chanda Zaveri Pigment Stabilizers

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
US3917578A (en) * 1973-12-10 1975-11-04 Ayerst Mckenna & Harrison Process for producing somatostatin and intermediates
US3882098A (en) * 1974-01-03 1975-05-06 American Home Prod Synthesis of des-Ala{hu 1{b , Gly{hu 2{b , Asn{hu 5{b -SRIF and intermediates
US4011207A (en) * 1974-12-27 1977-03-08 American Home Products Corporation Des-(Ala1, Gly2,Lys4 -Srif, Des-(Ala1, Gly2, Lys4)-D-Trp8 -Srif and intermediates
US3933784A (en) * 1975-01-27 1976-01-20 American Home Products Corporation Des-(ser13)-srif and intermediates

Also Published As

Publication number Publication date
CH639361A5 (de) 1983-11-15
JPS6141920B2 (xx) 1986-09-18
ATA213878A (de) 1981-07-15
AU519122B2 (en) 1981-11-12
BE865380A (fr) 1978-07-17
FR2385688A1 (fr) 1978-10-27
IE46862B1 (en) 1983-10-19
CA1102314A (en) 1981-06-02
AT366026B (de) 1982-03-10
FR2385688B1 (xx) 1983-10-07
GB1564191A (en) 1980-04-02
SE446190B (sv) 1986-08-18
US4105603A (en) 1978-08-08
DK131878A (da) 1978-09-29
ZA781599B (en) 1979-10-31
IE780511L (en) 1978-09-28
DE2813327C2 (xx) 1988-08-18
FI780907A7 (fi) 1978-09-29
IT7848586A0 (it) 1978-03-23
DE2813327A1 (de) 1978-10-05
JPS53130687A (en) 1978-11-14
ES468241A1 (es) 1978-12-01
SE7803318L (sv) 1978-09-29
NL7803289A (nl) 1978-10-02
AU3430778A (en) 1979-09-27
IT1105152B (it) 1985-10-28

Similar Documents

Publication Publication Date Title
LU79320A1 (fr) Procede de preparation de peptides exercant une activite biologique
LU80084A1 (fr) Procede de preparation d'oligoimides
BE869500A (fr) Procede de preparation de l'ethylene
PT64907B (fr) Procede de preparation d'une formulation a activite retarde
BE848601A (fr) Combinaisons a activite biologique, leur procede de preparation
BE865808A (fr) Procede de preparation de l'ethylene-glycol
BE865661A (fr) Procede de preparation de 3-alkyl-butene-1-als
BE862463A (fr) Procede de preparation de 2,5-dichlorophenol
BE864265A (fr) Procede de preparation d'acides alcoyl-carboxyliques superieurs
BE865201A (fr) Procede de preparation de 1-amino-3-aryloxy-2-propanols
LU79019A1 (fr) Procede de preparation d'une composition pesticide a activite synergique
BE870162A (fr) Procede de preparation de p-benzoquinonediacetals
BE869747A (fr) Procede de preparation d'un produit alimentaire proteique tekture
LU80272A1 (fr) Procede de preparation d'agents therapeutiques antiallergiques
BE852577A (fr) Procede de preparation d'un plancher double
BE865532A (fr) Procede de preparation de 2,2-dimethylolalcanals
BE865728A (fr) Procede de preparation du 2,3-dimethylpentanal
LU79074A1 (fr) Procede de preparation de benzyloxime ethers a activite pesticide
LU79540A1 (fr) Procede de preparation d'agents antibacteriens
PT68138A (fr) Procede de preparation de methoxy-2 benzamides
BE837303A (fr) Procede de preparation d'un produit a activite biologique
FR2322609A1 (fr) Composition presentant une activite biologique et son procede de preparation
BE865771A (fr) Procede de preparation d'une zeolite du type a finiment divisee
BE863350A (fr) Procede de preparation du tetramethyl-diacetal de la cyclohexane-dione-1,4
BE872383A (fr) Procede de preparation de phenylbutenones